Inceptiv™ spinal cord stimulator
Rechargeable spinal cord stimulator
with sensing technology
Inceptiv™ is the most advanced SCS system with closed-loop technology1-3 for chronic pain relief.
Download brochure
Overview
Pain relief in tune with life
Transforming SCS therapy through sensing†
Discover why the Inceptiv™ SCS system is the most advanced with automatic closed-loop sensing† technology, the best full body 1.5T and 3T MRI access‡, and the thinnest SCS device.
Need for consistent therapy
Fixed-output systems do not account for shifts in lead-to-spinal cord distance, which may result in inconsistent therapy dose.4
With fixed-output SCS systems, patients need to make adjustments to deliver optimal therapy, regardless of waveform. Under- and overdosing can lead to variable therapy experience.
Variability in electrode distance to spinal cord due to activities and position
Transforming SCS through sensing
Inceptiv™ SCS system senses† neural response and automatically adjusts stimulation in real time to maintain consistent therapy during all patient activities4-5. It addresses the variability in patient experience seen with fixed output SCS systems that may be due to inconsistent dosing. Overall, Inceptiv™ represents a significant advancement and is poised to transform SCS therapy options through sensing† now and tomorrow.
Automatic:
does not depend on adjustments from the patient to maintain stimulation
Responsive:
instantly adjusts therapy delivery in real time
Seamless:
provides consistent therapy while patients perform a full range of daily activities
Closed-loop algorithm senses neural response†,6
Your Inceptiv™ SCS patients can now enjoy greater freedom.
More consistent therapy, more time for life
Best full-body MRI access
The first and only full-body 1.5T and 3T MRI SCS system‡
84%
of patients are expected to need an
MRI within 5 years post implant7
90%
access to MRI scanners8,†
100%
access compared to 57% for Abbott, Boston Scientific, and Nevro patients due to high electrode impedance at 5 years†‡9
Inceptiv™ offers the most access to life-changing diagnostic imaging‡
Inceptiv™ advantage with SureScan™ portfolio
✔ Able to scan high impedance or fractured lead
✔ Able to scan fully discharged device
✔ 1.5T and 3T MR conditional whole body normal operating mode
✔ Able to scan patient in prone position, e.g., breast MRI
Continue reading about Inceptiv™
Download the brochure for more information on the game changer in chronic pain therapy — the Inceptiv™ system.
Read about
DTM™ SCS
Click to learn more about DTM™ SCS, a proprietary waveform supported by pre-clinical research and clinical research delivering Superior Pain Relief. Proven1.
† Sensing signals may not be measurable in all cases.
‡ Under specific conditions. Refer to product labeling for full list of conditions.
1
Fishman M, Cordner H, Justiz R, et al. Twelve-Month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021;21(8):912-923.
2
Inceptiv IFU with MRI labeling. M010773C002, M009826C003A,M939858A047A.
3
Evoke SCS System User Manual. Saluda Medical. D102706 Revision:7.00 4. Will A, Fishman
4
Will A, Fishman M, Schultz D, et al. Improvements in Therapy Experience With Evoked Compound Action Potential Controlled, Closed-Loop Spinal Cord Stimulation-Primary Outcome of the ECHO-MAC Randomized Clinical Trial. J Pain. 2024;25(11):104646. doi:10.1016/j.jpain.2024.104646
5
Medtronic Stimulation RC Clinician A71400 Programmer Application Programming Guide for Neurostimulation Systems for pain therapy. M009826C003A
6
Vallejo R, Chakravarthy K, Will A, Trutnau K, Dinsmoor D. A new direction for closed-loop spinal cord stimulation: combining contemporary therapy paradigms with evoked compound action potential sensing. J Pain Res. 2021;14:3909-3918. doi: 10.2147/JPR. S344568.
7
Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531-537
8
Diagnostic Imaging Equipment Servicing. Market Insights. Western Europe: Clarivate; 2022. Report No. 47031053
9
Mullins CF, Harris S, Pang D. A retrospective review of elevated lead impedances in impedance-dependent magnetic resonance conditional spinal cord stimulation devices. Pain Pract. 2023;00:1–8. https://doi.org/10.1111/papr.13301
This material should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s).
Please note that the intended use of a product may vary depending on geographical approvals. See the device manual(s) for detailed information regarding the intended use, the (implant) procedure, indications, contraindications, warnings, precautions, and potential adverse events. For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI.
If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website www.medtronic.com/manuals
Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser. Medtronic products placed on European markets comply with EU and UK legislation (if applicable) on medical devices. For any further information, contact your local Medtronic representative and/or consult Medtronic’s websites.